Question 1

How is site specific glycan heterogeneity measured?

Accepted Answer

Digestion must generate peptides carrying a single attachment site, which often means combining several proteases to get suitable coverage. Mass spectrometry then reports the distribution of structures present at that position. Averaging across the whole protein hides exactly the variation that determines antibody accessibility, so per site reporting matters.

Question 2

How can folding and transport defects be separated?

Accepted Answer

Pulse chase labelling with glycosidase treatment distinguishes molecules retained in early compartments from those that have progressed, since resistance to certain enzymes is acquired only after Golgi modification. Conformation dependent antibodies then indicate whether retained protein is misfolded or simply held, which points to different underlying causes.

Question 3

Why do cell lines change cleavage outcomes?

Accepted Answer

Protease expression varies widely between lines, so a protein processed efficiently in one background may remain uncleaved in another. Testing across several relevant lines, with inhibitors selective for different protease families, identifies which enzyme is responsible rather than assuming the one most often reported.

Question 4

What makes a cleavage site mutant informative?

Accepted Answer

Substituting residues at the recognition sequence should block processing without disturbing folding, so the mutant must be checked for normal transport and conformation. Comparing a cleavage blocked mutant against wild type in entry assays then attributes function to the processing step rather than to protein abundance or stability.

Question 5

How is surface display quantified reliably?

Accepted Answer

Flow cytometry on intact cells measures the external pool, while permeabilised samples give the total. The ratio reports trafficking efficiency independent of expression level. The antibody must recognise the native conformation, and a second reagent against a different epitope guards against results driven by one antibody behaviour.

Question 6

Does glycan trimming affect antigenic properties?

Accepted Answer

Yes, since the extent of processing determines whether sites carry high mannose or complex structures, and these differ in size, charge, and recognition by lectins and antibodies. Producing the same protein in cells with modified processing pathways lets the antigenic consequences of each glycan type be compared directly.

Microbiology

Microbiology

Research Frontiers in Viral Glycoprotein Processing and Trafficking